Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.

MLA

Zhu, Wei-Hang, et al. “Erythroid-Transdifferentiated Myeloid Cells Promote Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.” Theranostics, vol. 13, no. 13, July 2023, pp. 4316–32. EBSCOhost, https://doi.org/10.7150/thno.82907.

APA

Zhu, W.-H., Chen, J., Huang, R.-K., Zhang, Y., Huang, Z.-X., Pang, X.-Q., Hu, B., Yang, Y., & Li, X. (2023). Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma. Theranostics, 13(13), 4316–4332. https://doi.org/10.7150/thno.82907

Chicago

Zhu, Wei-Hang, Jie Chen, Run-Kai Huang, Yuan Zhang, Ze-Xuan Huang, Xiu-Qing Pang, Bo Hu, Yang Yang, and Xing Li. 2023. “Erythroid-Transdifferentiated Myeloid Cells Promote Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.” Theranostics 13 (13): 4316–32. doi:10.7150/thno.82907.